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OBJECTIVE: Laryngoscopy and stimuli inside the trachea cause an intense sympatho-adrenal response.
Remifentanil seems to be the optimal opioid for rigid bronchoscopy due to its potent and short-acting
properties. The purpose of this study was to compare bolus propofol and ketamine as an adjuvant to
remifentanil-based total intravenous anesthesia for pediatric rigid bronchoscopy.
MATERIALS AND METHODS: Forty children under 12 years of age who had been scheduled for a rigid
bronchoscopy were included in this study. After midazolam premedication, a 1 mg/kg/min remifentanil infusion
was started, and patients were randomly allocated to receive either propofol (Group P) or ketamine (Group K)
as well as mivacurium for muscle relaxation. Anesthesia was maintained with a 1 mg/kg/min remifentanil
infusion and bolus doses of propofol or ketamine. After the rigid bronchoscopy, 0.05 mg/kg/min of remifentanil
was maintained until extubation. Hemodynamic parameters, emergence characteristics, and adverse events
were evaluated.
RESULTS: The demographic variables were comparable between the two groups. The decrease in mean arterial
pressure from baseline values to the lowest values during rigid bronchoscopy was greater in Group P (p=0.049),
while the reduction in the other parameters and the incidence of adverse events were comparable between the
two groups. The need for assisted or controlled mask ventilation after extubation was higher in Group K.
CONCLUSION: Remifentanil-based total intravenous anesthesia with propofol or ketamine as an adjuvant drug
along with controlled ventilation is a viable technique for pediatric rigid bronchoscopy. Ketamine does not
provide a definite advantage over propofol with respect to hemodynamic stability during rigid bronchoscopy,
while propofol seems more suitable during the recovery period.
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Rigid bronchoscopy (RB) is the technique of choice for the
removal of tracheobronchial foreign bodies (1) also a useful
tool for other diagnostic or therapeutic purposes. Despite
its advantages, RB is more stimulating than fiberoptic
bronchoscopy and, therefore, requires general anesthesia.
Laryngoscopy and stimuli inside the trachea cause an
intense sympatho-adrenal response (2); therefore, it is
reasonable to use high-dose opioids during RB because
the noxious stimuli associated with RB have been shown to
be qualitatively similar to those of laryngoscopy but are
often greater and of longer duration (3). Remifentanil seems
to be the optimal opioid for RB with because of its potent
and ultra-short-acting properties. In addition, minimal
analgesia is required after the procedure.
The favorable pharmacokinetic profile and quick meta-
bolism of remifentanil and propofol make them agents of
choice for total intravenous anesthesia (TIVA) (4,5). Both
remifentanil and propofol can decrease blood pressure and
heart rate, and this hemodynamic effect can be additive
or synergistic with the combined use of both drugs (4,6).
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Ketamine has a minimal eaffect on ventilatory drive,
exhibits bronchodilating properties (7), and has been used
mostly for flexible bronchoscopy with spontaneous ventila-
tion (8). In contrast to remifentanil and propofol, ketamine
increases arterial blood pressure, heart rate, and cardiac
output (7,9). There is limited data regarding remifentanil-
based anesthesia for RB or data comparing ketamine and
propofol during remifentanil infusion. In this study, we
aimed to compare bolus infusions of propofol and ketamine
as an adjuvant to remifentanil-based anesthesia for pediatric
RB. The hemodynamic parameters, RB conditions, emer-
gence characteristics, and adverse events were evaluated.
& MATERIALS AND METHODS
After obtaining the approval of the Institutional Ethics
Committee and obtaining informed consent from the
parents, 40 consecutive children under 12 years of age
who were scheduled to undergo RB for diagnostic (sus-
pected foreign body aspiration, bronchoalveolar lavage)
and/or therapeutic purposes (removal of foreign bodies
and/or mucus plugs) were included. Patients were
excluded if they had severe cardiovascular disease; cerebral,
hepatic, or renal dysfunction; or neuromuscular disease.
Children with predicted difficulty in laryngoscopy and
intubation, those requiring prompt interventions for a life-
threatening situation (acutely compromised airway with
SpO2 values below 70%), and patients scheduled for
additional interventions or surgery subsequent to RB were
also excluded.
The fasting time before anesthesia induction was at least
six hours for solid foods and four hours for clear liquids.
Before admission to the preoperative holding area, a local
anesthetic cream was applied to the insertion site and
intravenous (IV) catheterization was performed. Midazolam
(0.05 mg/kg) was administered intravenously just before
admission to the operating room. Pulse oximetry (SpO2),
electrocardiogram (ECG), and non-invasive blood pressure
were monitored. Before induction, all children were pre-
oxygenated and a 10 mg/kg/h crystalloid infusion was
started. Children were randomly allocated to one of two
groups using sealed envelopes. After a second dose of
0.05 mg/kg of IV midazolam, a 1 mg/kg/min remifentanil
infusion (RI) was started. During the 1st minute of RI, 2-
4 mg/kg of propofol (Group P) or 2-3 mg/kg of ketamine
(Group K) was administered. To prevent propofol injection
pain, propofol was included 1 mg/ml of lidocaine. When
adequate mask ventilation was ensured, 0.15 mg/kg of
mivacurium was administered for muscle relaxation, and
RB was initiated during the 4th-5th minutes of RI. The depth
of anesthesia was assessed clinically based on hemody-
namic parameters (heart rate, blood pressure), movement,
coughing, bucking, lacrimation, and sweating. Additional
doses of propofol (0.5-1 mg/kg) or ketamine (0.25-0.5 mg/
kg), with or without mivacurium (0.025-0.05 mg/kg,
according to the bronchoscopy course), were administered
if the anesthesia was considered inadequate. A 1 mg/kg/
min remifentanil infusion was maintained throughout the
procedure.
Patients were manually ventilated with a ‘T’ piece
connected to the side arm of the rigid bronchoscope (Karl
Storz; Tuttlingen, Germany). The fresh gas flow was
adjusted to 6-10 l/min. In case of major air leakage, an
oxygen flush valve was used for adequate filling of the
reservoir bag and the airway pressure limit was adjusted to
20-30 cmH2O.
After bronchoscopy, endotracheal intubation was per-
formed and manually controlled or assisted ventilation with
4-8 cmH2O positive end-expiratory pressure (PEEP and 50%
oxygen in air was performed. Tracheal and oral secretions
were suctioned as needed, and the patients were turned to
the lateral decubitus position for recovery. After being
placed in the recovery position, no further stimulation was
allowed except gentle suctioning of oral secretions. For a
smooth extubation, RI was decreased to 0.05 mg/kg/min
and continued until just before extubation. When patients
began to demonstrate emergence from anesthesia by
displaying a regular respiratory pattern, facial grimacing,
or purposeful movement, the trachea was extubated. In
cases of breath-holding and arterial oxygen desaturation,
assisted or controlled mask ventilation was performed. Pure
oxygen was administered via the mask to maintain SpO2
above 94%.
Noninvasive blood pressure was measured before induc-
tion as a baseline value, after induction (just before
laryngoscopy), and in three-minute intervals during RB.
Hypotension was defined as a systolic blood pressure lower
than 60 mmHg for children under two years of age and
70 mmHg for children 2-12 years of age (10). Hypotension
was treated with an increase in IV crystalloid infusion, and
cases with two consecutive measures of hypotension were
treated with ephedrine and a decrease in the remifentanil
infusion. Bradycardia was defined as a heart rate slower
than 80 beats/min for infants and 60 beats/min for older
children (11) and was treated with atropine 0.01 mg/kg.
SpO2 values below 90% were defined as hypoxemia.
The severity of hypoxemia was graded as mild (SpO2: 80-
89%), moderate (SpO2: 70-79%), or severe (SpO2: ,70%).
Coughing or respiratory effort (diaphragm movement) and
limb movement during laryngoscopy and RB were graded
as mild (minor movement that does not affect surgical
comfort), moderate (affects surgical comfort), or severe (the
bronchoscope has to be removed to prevent complications)
by the endoscopist. Postoperative severe restlessness and
disorientation with purposeless activity were defined as
emergence agitation. All adverse events were recorded by
an independent observer.
The primary outcome of the study was the change in
systolic arterial pressure during RB. A pilot study was
performed with the technique used for Group P. A power
analysis showed that a minimum sample size of 40 patients
(20 in each group) was required to detect a 20% change in
systolic arterial pressure at a power level of 90% with
p,0.05. Categorical variables and hemodynamic parame-
ters were analyzed using the Mann-Whitney U test and
repeated-measures analysis of variance (ANOVA), respec-
tively. A comparison of the incidence of the outcomes
between the two groups was performed using a two-tailed
Fisher’s exact test. The results were considered to be
statistically significance at p,0.05.
& RESULTS
Patient and anesthesia characteristics are listed in Table 1.
The age, weight, gender distribution, and duration of RB
were comparable between the two groups. One patient in
Group P developed respiratory distress and was excluded.
It was not possible to introduce the rigid bronchoscope in
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this patient; therefore, an optical telescope was used while
manually controlled ventilation was performed successfully
with a nasopharyngeal tube. The same consultant with four
years of experience in pediatric anesthesia administered
the anesthesia for all procedures. Six different endoscopists
(four residents and two pediatric surgery consultants)
performed the RB. RB was sometimes started by a non-
experienced endoscopist (resident) for training and was
completed by consultants. Midazolam, mivacurium, atro-
pine, and steroid administrations were comparable between
the two groups.
The underlying diagnoses of respiratory impairment
(noted after RB) are listed in Table 2. Additionally, there
were two patients with a diagnosis of ventricular septal
defect and West syndrome (a form of epilepsy) in Group P.
The hemodynamic parameters before and after induction
and the highest and lowest values during RB are listed in
Table 3. The baseline heart rate, baseline arterial pressures
(systolic, mean, and diastolic), and the reduction in HR and
arterial pressures after induction were comparable between
the groups; however, the decrease in the mean arterial
pressure from baseline values to the lowest values during
RB was significantly higher in Group P (p= 0.049). The
differences in other hemodynamic parameters were com-
parable. No participants in either group had hypotension
in two consecutive measurements or were administered
ephedrine. In a 14-month-old boy in Group K, the
remifentanil infusion had to be decreased due to persistent
bradycardia despite atropine administration, and other
bradycardia events in Group K were due to severe desatura-
tion during emergence. The only atropine administration in
Group P occurred during a prolonged laryngoscopy.
The emergence characteristics are listed in Table 4. After
decreasing RI to 0.05 mg/kg/min, the time to extubation (A)
was comparable between the two groups, but the incidence
of controlled and/or assisted mask ventilation (B) and
the duration of mask ventilation (C) after extubation were
significantly higher in Group K. The restoration of sponta-
neous ventilation without assistance (D=A+C) and eye
opening (E) were comparable between the groups.
The adverse events are listed in Table 5. The differences in
the incidences of adverse events were not statistically
significant. The number of desaturation episodes during
the procedure is listed in Table 6. Four patients in Group P
and five patients in Group K experienced mild desaturation,
while one patient in Group P and one patient in Group K
experienced moderate desaturation at room air before the
procedure. Four patients in Group P and eight patients in
Group K experienced 4 and 12 episodes of desaturation,
respectively, during the procedure (p.0.05). One patient in
Group P and five patients in Group K had severe
desaturation episodes (p.0.05). Severe desaturation epi-
sodes during induction and laryngoscopy were of short
duration. The desaturation incidence that occurred during
bronchoscopy was due to a fragmented organic foreign
body, and the other incidences were due to bronchospasm.
All patients were transferred to the recovery ward with
SpO2 values above 94% with or without supplemental
oxygen.
& DISCUSSION
The addition of a ketamine infusion to anesthesia with a
remifentanil infusion has been previously investigated, and
the results demonstrated hemodynamic stability and less
frequent adverse events, such as bradycardia and hypoten-
sion (12-14); however, the combined use of remifentanil and
ketamine without any other adjuvant was not previously
investigated. In this study, the hemodynamic effects of
Table 1 - Patient and anesthesia characteristics.
Group P Group K
Age (years) 3.9 (¡4) 3.3 (¡3)
Weight (kg) 15.7 (¡10) 14.9 (¡6)
Gender (Male/Female) 12/8 13/7
Duration of RB (min) 13.9 (¡6.7) 10.3 (¡4)
Total midazolam administered (mg/kg) 0.09 (¡0.02) 0.10 (¡0.01)
Propofol induction dose (mg/kg) 2.87 (¡0.52) -
Total propofol administered (mg/kg) 4.75 (¡1.94) -
Total lidocaine administered (mg/kg) 0.47 (¡0.19) -
Ketamine induction dose (mg/kg) - 2.30 (¡0.39)
Total ketamine administered (mg/kg) - 2.87 (¡0.67)
Mivacurium induction dose (mg/kg) 0.16 (¡0.04) 0.16 (¡0.04)
Total mivacurium administered (mg/kg) 0.18 (¡0.05) 0.18 (¡0.04)
Additional mivacurium (n= ) 6 8
Atropine administration (n= ) 1 3
IV steroid administration (n= ) 4 6
Values are expressed as the mean¡SD or number of patients (n). RB: rigid
bronchoscopy.
Table 2 - Diagnosis after rigid bronchoscopy.
Group P Group K







Upper respiratory tract infection 3 2
Postoperative pulmonary atelectasis 1 1
Unknown diagnosis 2 2
Values are expressed as the number of patients.
Table 3 - Hemodynamic parameters.
Group P Group K
HR (beats/min) BI 129 (¡26) 132 (¡26)
AI 108 (¡24) 105 (¡22)
HIGH 119 (¡24) 124 (¡18)
LOW 99 (¡22) 107 (¡21)
SAP (mmHg) BI 98 (¡15) 106 (¡14)
AI 77 (¡9) 85 (¡15)
HIGH 86 (¡8) 101 (¡13)
LOW 75 (¡8) 90 (¡14)
MAP (mmHg) BI 77 (¡13) 80 (¡13)
AI 56 (¡8) 59 (¡11)
HIGH 64 (¡7) 75 (¡12)
LOW* 53 (¡7) 64 (¡10)
DAP (mmHg) BI 61 (¡13) 66 (¡13)
AI 42 (¡8) 46 (¡11)
HIGH 50 (¡8) 62 (¡12)
LOW 39 (¡6) 50 (¡10)
Values are expressed as the mean¡SD; HR, heart rate; SAP, systolic arterial
pressure; MAP, mean arterial pressure; DAP, diastolic arterial pressure; BI,
baseline values before induction; AI, values after induction, just before
the laryngoscopy; HIGH, highest values during bronchoscopy; LOW,
lowest values during bronchoscopy. *: p=0.049, when comparing the
decreases from the baseline values.
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bolus propofol and ketamine as adjuvants to remifentanil-
based anesthesia for RB in pediatric patients were com-
pared. With regard to the decline in mean arterial pressures
from baseline values to the lowest values during RB,
ketamine seemed slightly more advantageous than propo-
fol. If we had used lower remifentanil infusion rates and
higher doses of adjunct drugs (propofol or ketamine), the
difference in hemodynamic parameters may have been
more significant. In addition, the incidence of hypotension
and bradycardia was low in both groups, likely due to the
high sympatho-adrenal stimulation of RB.
Regarding emergence characteristics, the need for mask
ventilation and the duration of mask ventilation after
extubation were higher in Group K. This finding may be
due to the longer duration of action of ketamine and the
maintenance of remifentanil infusion during emergence,
which may cause apnea. Airway reactions after extubation
may be another explanation. As the remifentanil-ketamine
combination is a less common anesthesia technique,
different clinical features of ketamine (dissociative anesthe-
sia) may also cause confusion among anesthesiologists
regarding the appropriate timing of extubation.
Despite its bronchodilating capabilities and fewer respira-
tory depressant properties, ketamine has been associated
with laryngospasm, increased oral secretions, and altera-
tions in pulmonary artery pressure, pulmonary vascular
resistance, and oxygen consumption (7-9), which may
explain why Group K patients had more desaturation
episodes during the RB procedure. A higher sample size
may demonstrate significant differences in the incidence of
desaturation. An antisialagogue premedication may have
been beneficial in Group K.
Adjunct remifentanil use during RB with propofol or
inhalational anesthetics along with either spontaneous or
controlled ventilation has been described previously (15-21).
The infusion rates of remifentanil were 0.5 mg/kg/min or
lower in those studies. A similar protocol as that used in
Group P was used for general anesthesia with controlled
ventilation during RB of adult patients with American
Society of Anesthesiologists (ASA) physical status III, but
with relatively lower infusion rates of remifentanil (0.5 mg/
kg/min), a propofol infusion, and 0.25 mg/kg mivacurium
(16). A 0.3-1 mg/kg/min remifentanil infusion and propofol
infusion with muscle relaxants during endolaryngotracheal
surgery in pediatric patients have also been described, but
the hemodynamic parameters were not reported (21).
There are several acceptable general anesthesia techni-
ques for RB. Although inhalation anesthesia with sponta-
neous ventilation is the most popular technique (22), there is
no strong evidence for the superiority of this technique
for RB. There are limited data on TIVA and controlled
ventilation for pediatric RB. The use of inhalation anes-
thetics during RB is a major risk factor for the exposure of
operating room personnel to anesthetics (23), while TIVA is
the definite solution to this problem. In addition, immobi-
lization of the patient and controlled ventilation allow for
suitable laryngoscopy and RB conditions (22,24).
The skill and experience of the endoscopist (as well as the
anesthetist) are crucial for preventing adverse events and
complications during RB and foreign body removal. Non-
experienced endoscopists, as was the case in this recent
study, may sometimes initiate RB for training purposes.
Table 4 - Emergence characteristics.
Group P Group K p
A- Time to extubation* (min) 18.7 (¡5.9) 15.1 (¡6.9) NS
B- Controlled and/or assisted mask ventilation** (n) 4 13 0.0095
C- Duration of mask ventilation** (min) 0.55 (¡1.3) 6.65 (¡10.3) 0.001
D- Time to spontaneous ventilation without assistance* (min) 19.2 (¡5.8) 21.7 (¡11.2) NS
E- Time to eye opening* (min) 27 (¡9.1) 30.2 (¡16) NS
Values are expressed as the mean (¡SD) or number of patients (n).
*: After decreasing the remifentanil infusion to 0.05 mg/kg/min.
**: After extubation.
NS: not significant.
Table 5 - Adverse events.
Group P Group K
Midazolam-related agitation 1 1
Bradycardia
During laryngoscopy 1 0
During bronchoscopy 0 1
During emergence 0 2
Total 1 3
Hypotension
After induction 3 3






Severe desaturation 1 5
Bronchospasm 0 2
aryngospasm 0 1
Postoperative nausea and vomiting 1 4
Emergence agitation 1 3
Values are expressed as the number of patients.
Table 6 - Desaturation episodes.
Group P Group K
Mild Moderate Severe Mild Moderate Severe
Before procedure 4 1 - 5 1 -
During induction - - 1 3 - 1
During laryngoscopy 1 - - 1 1 1
During bronchoscopy 1 1 - 1 - 1
Before extubation* - - - - - 1
After extubation - - - - 1 1
Total during
procedure
2 1 1 5 2 5
Values are expressed as the number of episodes.
*: After decreasing remifentanil infusion to 0.05 mg/kg/min.
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Prolonged laryngoscopy, traumatic insertion of the rigid
bronchoscope, and dislodgement of the foreign body may
cause serious adverse events, while a relaxed glottis and
abducted vocal cords may simplify laryngoscopy, bron-
choscope insertion, and foreign body removal (22,24).
Coughing and movement of the patient (even respiratory
movement) may have a negative impact on the concentra-
tion of the endoscopist (especially in non-experienced
physicians) and could increase morbidities, such as airway
injury, pneumothorax, or hemorrhage; thus, immobilization
is crucial (22,24). For these reasons, once adequate mask
ventilation is established, controlled ventilation is usually
our technique of choice in RB. In this study, while complete
immobilization during RB was achieved in only half of the
patients, there were no movements affecting surgical
comfort and outcome. There are many studies describing
successful intubation with remifentanil without the use of a
neuromuscular blocking agent (25). This study may have
been performed without the use of neuromuscular blocking
agents; however, this may have increased the use of
adjuvants and changed the hemodynamic and emergence
characteristics. To prevent the need for antagonists and their
adverse effects, we aimed to limit the use of mivacurium.
Acceptable muscle relaxation and immobilization was
achieved in both groups with a total dose of 0.18 mg/kg
of mivacurium, which is administered at a standard dose of
0.25 mg/kg for endotracheal intubation of children (26). A
lack of neuro-muscular monitoring may be a weakness of
this study.
Maintaining the remifentanil infusion during emergence
from anesthesia and tracheal extubation has been described
previously (27). This technique was used after propofol-
remifentanil anesthesia in adult patients and was found to
reduce hemodynamic changes and coughing associated
with extubation. Opioid-based TIVA or maintenance of the
remifentanil infusion during extubation is our technique of
choice for children with a high risk of airway reactions. It is
reasonable to ignore extended emergence times when
aiming to decrease the incidence of airway reactions in
high-risk patients. Based on the emergence characteristics in
our study, this technique may not be suitable for ketamine
anesthesia.
Intermittent propofol injections instead of continuous
infusion during rigid bronchoscopy may be preferred as a
practical technique in some centers (17,28), as in our
institution. In this study, to decrease the recovery time
and risk of awareness, propofol or ketamine infusions
instead of bolus doses and bispectral index monitoring may
be more appropriate. However, Bould et al. (28) found no
difference in the bispectral index (BIS) values of patients
anesthetized for elective RB with intermittent boluses or
target controlled infusions of propofol. In addition, bispec-
tral index monitoring was found to be unreliable in the case
of ketamine use (29).
In conclusion, remifentanil-based TIVA with propofol or
ketamine as an adjuvant drug along with controlled
ventilation is a viable technique for pediatric RB. The
intense stimulation associated with RB was well suppressed
with a 1 mg/kg/min remifentanil infusion, which also
secured hemodynamic stability. Propofol appeared to be
more suitable in the recovery period of remifentanil-based
anesthesia for RB of pediatric patients, while ketamine use
instead of propofol did not provide a definite advantage
when hemodynamic stability during RB is considered.
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